David L. Heymann

Nota: Este archivo abarca los artículos publicados por el autor desde el 1 de mayo de 2009. Para fechas anteriores realice una búsqueda entrecomillando su nombre.

Antimicrobial resistance (AMR), where the ability of a drug to treat an infection is compromised, reached the highest political level last week with the convening of a UN General Assembly meeting dedicated to the threat. With estimates of 700,000 deaths occurring each year due to drug-resistant infections and the World Bank projecting that if left unchecked, the problem could cause annual global GDP to fall between 1.1% and 3.8% before 2050, all member states adopted a political declaration that outlined commitment to a broad range of interventions. The first of its kind, the declaration rightfully recognized that combating AMR demands a multi-pronged approach, including raising awareness of the threat and its solutions; more prudent use of current drugs; replenishing the pipeline of antibiotics; developing new types of drugs, rapid diagnostic tests and vaccines; closer collaboration between the agricultural and human health sectors, and sustained funding for implementing national plans.…  Seguir leyendo »

In the early hours of March 15, 2003, I was awakened by a telephone call at my home in Geneva from the infectious disease duty officer of the World Health Organization, who had just received a call from the health authorities in Singapore.

He said that a doctor in the city-state who had been treating patients with the unusual respiratory disease that we were monitoring had become ill with the same symptoms while flying back from a medical conference in New York. His plane was due to stop in Frankfurt.

Our first step was to alert the German health authorities and advise them to consider taking the doctor off the plane to reduce exposure to other passengers, and to put him under immediate medical supervision.…  Seguir leyendo »